CLADRIBINE

Cladribine

 

Composition: each vial contains:

active ingredient: cladribine – 10 mg.

Therapeutic indications

Hairy Cell Leukemia.

Chronic lymphatic leukemia (progressing forms and the ones resistant to first line polychemotherapy drugs).

Low-grade and intermediate magliant non-Hodgkin's lymphomas.

ATC code

L01BB04

Pharmaceutical form

solution for injection 1 mg/ml

Storage conditions

Store in protected from light place at temperature between 2°C and 8°C.